{"id":5611,"date":"2014-06-03T07:25:58","date_gmt":"2014-06-03T06:25:58","guid":{"rendered":"http:\/\/blog.protrainings.eu\/?p=5611"},"modified":"2014-06-03T07:25:58","modified_gmt":"2014-06-03T06:25:58","slug":"skin-cancer-trial-results-exciting","status":"publish","type":"post","link":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/","title":{"rendered":"Skin cancer trial results &#8216;exciting&#8217;"},"content":{"rendered":"<p class=\"introduction\" style=\"font-weight: bold;\">Both treatments, for advanced melanoma, are designed to enable the immune system to recognise and target tumours.<\/p>\n<p>The findings were released at the American Society of Clinical Oncology conference in Chicago. \u00a0The experimental drugs, pembrolizumab and nivolumab, block the biological pathway cancers use to disguise themselves from the immune system. \u00a0 Advanced melanoma &#8211; skin cancer which has spread to other organs &#8211; has proved very hard to treat. \u00a0Until a few years ago average survival was around six months.<!--more--><\/p>\n<p><span class=\"cross-head\" style=\"font-weight: bold; color: #505050;\">Improved survival<\/span><\/p>\n<p>In a trial of 411 patients evaluating pembrolizumab &#8211; 69% of patients survived at least a year. \u00a0The drug, which used to be known as MK-3475, is also being tested against other tumour types which use the same mechanism to block attack from the immune system. \u00a0Dr David Chao, consultant oncologist at the Royal Free London NHS Foundation Trust, is conducting trials in both melanoma and lung cancer patients. He said: \u00a0&#8220;Pembrolizumab looks like it has potential to be a paradigm shift for cancer therapy.&#8221;<\/p>\n<p>One of his patients, Warwick Steele, aged 64, has been receiving infusions of pembrolizumab every three weeks since October. \u00a0Before the treatment started he could barely walk because the melanoma had spread to one of his lungs and he found it hard to breathe. \u00a0&#8220;I got tired simply standing up and was literally too exhausted to shave. But now I feel back to normal and can do gardening and go shopping&#8221;. \u00a0Scans of his lungs &#8211; shown above &#8211; reveal that after just three infusions, the drug appears to have completely cleared the cancer from his lung.<\/p>\n<p>Read the full story at\u00a0http:\/\/<a href=\"http:\/\/www.bbc.co.uk\/news\/health-27674658\" target=\"_blank\">www.bbc.co.uk\/news\/health-27674658<\/a><\/p>\n<h3 class=\"zemanta-related-title\" style=\"margin: 0 0 10px 0; padding: 0; clear: both;\">Related articles across the web<\/h3>\n<ul class=\"zemanta-article-ul zemanta-article-ul-image\" style=\"margin: 0; padding: 0; overflow: hidden;\">\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"padding: 0; background: none; list-style: none; display: block; float: left; vertical-align: top; text-align: left; width: 104px; font-size: 12px; margin: 0 5px 10px 0;\"><a style=\"padding: 2px; display: block; text-decoration: none;\" href=\"http:\/\/www.protrainings.uk\/blog\/course-of-the-week-basic-life-support-for-dentists\/\" target=\"_blank\"><img decoding=\"async\" style=\"border-radius: 3px; box-shadow: 0 1px 4px rgba(0, 0, 0, 0.2); padding: 0; margin: 0; border: 0; display: block; width: 100px; max-width: 100%;\" src=\"http:\/\/i.zemanta.com\/273792908_150_150.jpg\" alt=\"\" \/><\/a><a style=\"display: block; overflow: hidden; text-decoration: none; line-height: 12pt; height: 80px; padding: 5px 2px 0 2px;\" href=\"http:\/\/www.protrainings.uk\/blog\/course-of-the-week-basic-life-support-for-dentists\/\" target=\"_blank\">Course of the week &#8211; Basic Life Support for Dentists<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"padding: 0; background: none; list-style: none; display: block; float: left; vertical-align: top; text-align: left; width: 104px; font-size: 12px; margin: 0 5px 10px 0;\"><a style=\"padding: 2px; display: block; text-decoration: none;\" href=\"http:\/\/www.protrainings.uk\/blog\/important-safety-information-for-patients-using-jext-solution-for-injection-in-pre-filled-pen\/\" target=\"_blank\"><img decoding=\"async\" style=\"border-radius: 3px; box-shadow: 0 1px 4px rgba(0, 0, 0, 0.2); padding: 0; margin: 0; border: 0; display: block; width: 100px; max-width: 100%;\" src=\"http:\/\/i.zemanta.com\/238689128_150_150.jpg\" alt=\"\" \/><\/a><a style=\"display: block; overflow: hidden; text-decoration: none; line-height: 12pt; height: 80px; padding: 5px 2px 0 2px;\" href=\"http:\/\/www.protrainings.uk\/blog\/important-safety-information-for-patients-using-jext-solution-for-injection-in-pre-filled-pen\/\" target=\"_blank\">Important safety information for patients using Jext solution for injection in pre-filled pen<\/a><\/li>\n<li class=\"zemanta-article-ul-li-image zemanta-article-ul-li\" style=\"padding: 0; background: none; list-style: none; display: block; float: left; vertical-align: top; text-align: left; width: 104px; font-size: 12px; margin: 0 5px 10px 0;\"><a style=\"padding: 2px; display: block; text-decoration: none;\" href=\"http:\/\/www.protrainings.uk\/blog\/keep-taking-statins-says-drug-body\/\" target=\"_blank\"><img decoding=\"async\" style=\"border-radius: 3px; box-shadow: 0 1px 4px rgba(0, 0, 0, 0.2); padding: 0; margin: 0; border: 0; display: block; width: 100px; max-width: 100%;\" src=\"http:\/\/i.zemanta.com\/275322263_150_150.jpg\" alt=\"\" \/><\/a><a style=\"display: block; overflow: hidden; text-decoration: none; line-height: 12pt; height: 80px; padding: 5px 2px 0 2px;\" href=\"http:\/\/www.protrainings.uk\/blog\/keep-taking-statins-says-drug-body\/\" target=\"_blank\">Keep taking statins&#8217; says drug body<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Both treatments, for advanced melanoma, are designed to enable the immune system to recognise and target tumours. The findings were released at the American Society of Clinical Oncology conference in Chicago. \u00a0The experimental drugs, pembrolizumab and nivolumab, block the biological pathway cancers use to disguise themselves from the immune system. \u00a0 Advanced melanoma &#8211; skin [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,13,14],"tags":[202,517,518,519,520,521,522],"class_list":["post-5611","post","type-post","status-publish","format-standard","hentry","category-50-plus-first-aid","category-first-aid-at-work","category-online-learning","tag-cancer","tag-lung","tag-melanoma","tag-mk-3475","tag-oncology","tag-pembrolizumab","tag-skin-cancer"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Skin cancer trial results &#039;exciting&#039; - Online Health &amp; Safety Training Courses | ProTrainings Europe<\/title>\n<meta name=\"description\" content=\"First Aid News and Updates\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skin cancer trial results &#039;exciting&#039; - Online Health &amp; Safety Training Courses | ProTrainings Europe\" \/>\n<meta property=\"og:description\" content=\"First Aid News and Updates\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/\" \/>\n<meta property=\"og:site_name\" content=\"Online Health &amp; Safety Training Courses | ProTrainings Europe\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/protrainingsuk\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-03T06:25:58+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/i.zemanta.com\/273792908_150_150.jpg\" \/>\n<meta name=\"author\" content=\"Keith Sleightholm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@protrainingsuk\" \/>\n<meta name=\"twitter:site\" content=\"@protrainingsuk\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Keith Sleightholm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/\"},\"author\":{\"name\":\"Keith Sleightholm\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#\\\/schema\\\/person\\\/1d4ce8b0d78ec0a52ce02f89849bed58\"},\"headline\":\"Skin cancer trial results &#8216;exciting&#8217;\",\"datePublished\":\"2014-06-03T06:25:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/\"},\"wordCount\":311,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/i.zemanta.com\\\/273792908_150_150.jpg\",\"keywords\":[\"cancer\",\"lung\",\"melanoma\",\"MK-3475\",\"Oncology\",\"Pembrolizumab\",\"Skin cancer\"],\"articleSection\":[\"50 Plus First Aid\",\"First Aid at Work\",\"online learning\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/\",\"url\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/\",\"name\":\"Skin cancer trial results 'exciting' - Online Health &amp; Safety Training Courses | ProTrainings Europe\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/i.zemanta.com\\\/273792908_150_150.jpg\",\"datePublished\":\"2014-06-03T06:25:58+00:00\",\"description\":\"First Aid News and Updates\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#primaryimage\",\"url\":\"http:\\\/\\\/i.zemanta.com\\\/273792908_150_150.jpg\",\"contentUrl\":\"http:\\\/\\\/i.zemanta.com\\\/273792908_150_150.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/skin-cancer-trial-results-exciting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skin cancer trial results &#8216;exciting&#8217;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/\",\"name\":\"Online Health & Safety Training Courses | ProTrainings Europe\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#organization\",\"name\":\"Online Health & Safety Training Courses | ProTrainings Europe\",\"url\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo.svg\",\"width\":175,\"height\":57,\"caption\":\"Online Health & Safety Training Courses | ProTrainings Europe\"},\"image\":{\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/protrainingsuk\",\"https:\\\/\\\/x.com\\\/protrainingsuk\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/#\\\/schema\\\/person\\\/1d4ce8b0d78ec0a52ce02f89849bed58\",\"name\":\"Keith Sleightholm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g\",\"caption\":\"Keith Sleightholm\"},\"sameAs\":[\"https:\\\/\\\/www.protrainings.uk\"],\"url\":\"https:\\\/\\\/www.protrainings.uk\\\/blog\\\/author\\\/keith-sleightholm\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skin cancer trial results 'exciting' - Online Health &amp; Safety Training Courses | ProTrainings Europe","description":"First Aid News and Updates","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/","og_locale":"en_GB","og_type":"article","og_title":"Skin cancer trial results 'exciting' - Online Health &amp; Safety Training Courses | ProTrainings Europe","og_description":"First Aid News and Updates","og_url":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/","og_site_name":"Online Health &amp; Safety Training Courses | ProTrainings Europe","article_publisher":"https:\/\/www.facebook.com\/protrainingsuk","article_published_time":"2014-06-03T06:25:58+00:00","og_image":[{"url":"http:\/\/i.zemanta.com\/273792908_150_150.jpg","type":"","width":"","height":""}],"author":"Keith Sleightholm","twitter_card":"summary_large_image","twitter_creator":"@protrainingsuk","twitter_site":"@protrainingsuk","twitter_misc":{"Written by":"Keith Sleightholm","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#article","isPartOf":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/"},"author":{"name":"Keith Sleightholm","@id":"https:\/\/www.protrainings.uk\/blog\/#\/schema\/person\/1d4ce8b0d78ec0a52ce02f89849bed58"},"headline":"Skin cancer trial results &#8216;exciting&#8217;","datePublished":"2014-06-03T06:25:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/"},"wordCount":311,"commentCount":0,"publisher":{"@id":"https:\/\/www.protrainings.uk\/blog\/#organization"},"image":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#primaryimage"},"thumbnailUrl":"http:\/\/i.zemanta.com\/273792908_150_150.jpg","keywords":["cancer","lung","melanoma","MK-3475","Oncology","Pembrolizumab","Skin cancer"],"articleSection":["50 Plus First Aid","First Aid at Work","online learning"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/","url":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/","name":"Skin cancer trial results 'exciting' - Online Health &amp; Safety Training Courses | ProTrainings Europe","isPartOf":{"@id":"https:\/\/www.protrainings.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#primaryimage"},"image":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#primaryimage"},"thumbnailUrl":"http:\/\/i.zemanta.com\/273792908_150_150.jpg","datePublished":"2014-06-03T06:25:58+00:00","description":"First Aid News and Updates","breadcrumb":{"@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#primaryimage","url":"http:\/\/i.zemanta.com\/273792908_150_150.jpg","contentUrl":"http:\/\/i.zemanta.com\/273792908_150_150.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.protrainings.uk\/blog\/skin-cancer-trial-results-exciting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.protrainings.uk\/blog\/"},{"@type":"ListItem","position":2,"name":"Skin cancer trial results &#8216;exciting&#8217;"}]},{"@type":"WebSite","@id":"https:\/\/www.protrainings.uk\/blog\/#website","url":"https:\/\/www.protrainings.uk\/blog\/","name":"Online Health & Safety Training Courses | ProTrainings Europe","description":"","publisher":{"@id":"https:\/\/www.protrainings.uk\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.protrainings.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.protrainings.uk\/blog\/#organization","name":"Online Health & Safety Training Courses | ProTrainings Europe","url":"https:\/\/www.protrainings.uk\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.protrainings.uk\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.protrainings.uk\/blog\/wp-content\/uploads\/2025\/05\/logo.svg","contentUrl":"https:\/\/www.protrainings.uk\/blog\/wp-content\/uploads\/2025\/05\/logo.svg","width":175,"height":57,"caption":"Online Health & Safety Training Courses | ProTrainings Europe"},"image":{"@id":"https:\/\/www.protrainings.uk\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/protrainingsuk","https:\/\/x.com\/protrainingsuk"]},{"@type":"Person","@id":"https:\/\/www.protrainings.uk\/blog\/#\/schema\/person\/1d4ce8b0d78ec0a52ce02f89849bed58","name":"Keith Sleightholm","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e9cd9e0b631a9c070c09d80ebf33c198ab8d7a236174589cf897864c850f658?s=96&d=mm&r=g","caption":"Keith Sleightholm"},"sameAs":["https:\/\/www.protrainings.uk"],"url":"https:\/\/www.protrainings.uk\/blog\/author\/keith-sleightholm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/posts\/5611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/comments?post=5611"}],"version-history":[{"count":0,"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/posts\/5611\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/media?parent=5611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/categories?post=5611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.protrainings.uk\/blog\/wp-json\/wp\/v2\/tags?post=5611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}